Navigating Anthem (Elevance Health) Xarelto Prior Authorization

Efficiently manage Anthem (Elevance Health) Xarelto prior authorization requests. Klivira provides the clarity and automation needed to navigate specific payer requirements for rivaroxaban.

Prior authorization for high-volume medications like Xarelto (rivaroxaban) can significantly impact revenue cycle efficiency and patient access to critical care. For healthcare providers serving Anthem (Elevance Health) members, understanding the specific submission channels, policy criteria, and appeal pathways is essential. This guide outlines the key considerations for securing timely approvals for Xarelto.

Understanding Xarelto and Anthem Formulary Requirements

Xarelto (rivaroxaban) is a direct oral anticoagulant (DOAC) prescribed for conditions like atrial fibrillation and venous thromboembolism (VTE). For Anthem-licensed plans, Xarelto's formulary tier and specific utilization management criteria, including potential step therapy requirements, are managed by CarelonRx, Elevance Health's in-house PBM. Providers should consult the specific state-plan formulary to verify coverage details and quantity limits.

Key Prior Authorization Submission Channels for Anthem Xarelto

**Pharmacy Benefit (Retail):** Prescriber-initiated Xarelto PAs route through CarelonRx's provider PA system or via electronic prior authorization (ePA) platforms like CoverMyMeds and Surescripts.
**Medical Benefit (Specialty):** While Xarelto is typically a pharmacy benefit drug, some specialty injectables and infusions on the medical benefit for Anthem members are subject to specific site-of-care and clinical-indication policies, potentially routing through Carelon.
**Availity Essentials:** For any medical benefit PA components related to Xarelto's administration or associated services, Anthem-licensed plans utilize Availity Essentials for PA initiation and document upload.
**X12 278 Transactions:** Klivira facilitates X12 278 submissions via clearinghouses for medical benefit prior authorizations, offering an automated channel for applicable services.

Accessing Anthem's Utilization Management Policies for Rivaroxaban

Anthem operating companies publish medical policies and clinical utilization management guidelines through provider sites accessible via Availity. For Xarelto, specific criteria, including step therapy and quantity limits, are typically found within the state-specific formulary and pharmacy benefit guidelines managed by CarelonRx. Always reference the specific policy number, plan-state context, and effective date.

Turnaround Timeframes for Anthem Xarelto PA Decisions

Prior authorization decision timeframes for Anthem-licensed plans vary by line of business and state. Commercial PA timeframes are governed by state insurance regulations. For Medicare Advantage, Medicaid managed care (under Anthem Medicaid and Wellpoint), and QHP-on-FFM plans, Anthem is impacted by CMS-0057-F, mandating 72-hour standard and 24-hour expedited PA decision timeframes on a phased compliance timeline.

Common Denial Reasons and Appeal Pathways for Xarelto

**Medical Necessity / Insufficient Documentation:** Lack of comprehensive clinical data supporting the use of rivaroxaban for the indicated condition.
**Step Therapy Not Completed:** Failure to document adherence to required step therapy protocols for Xarelto.
**Non-Formulary Pharmacy Denials:** Prescribing Xarelto when a preferred alternative is available or failing to meet non-formulary exception criteria.
**Appeal Process:** Denials are returned via X12 277/835 transactions and Availity status updates. Appeals for standard pharmacy or medical PA route through the Anthem operating-company appeals process, with peer-to-peer reviews available.

Klivira's Role in Streamlining Anthem Xarelto Prior Authorization

Klivira integrates with EMRs and payer portals, automating the submission and tracking of prior authorizations for medications like Xarelto. Our platform helps revenue cycle teams navigate the complexities of Anthem's diverse submission channels, including ePA partners like CoverMyMeds and Surescripts, and X12 278 transactions, reducing manual effort and accelerating decision times.

Frequently asked questions

How do I submit a prior authorization for Xarelto for an Anthem member?

For Xarelto, which is typically a pharmacy benefit drug, prior authorizations are primarily submitted through CarelonRx's provider portal or via ePA platforms like CoverMyMeds and Surescripts. For any associated medical benefit services, submissions would occur through Availity Essentials or via X12 278 transactions.

Where can I find Anthem's specific medical policies for Xarelto (rivaroxaban)?

Anthem operating companies publish medical policies and clinical guidelines on their provider websites, accessible via Availity. For Xarelto, specifically look for formulary documents and pharmacy benefit management guidelines, typically managed by CarelonRx, which will detail specific criteria, step therapy, and quantity limits.

What are the typical turnaround times for Xarelto prior authorizations with Anthem?

Turnaround times depend on the specific Anthem plan and state regulations. For commercial plans, state insurance mandates apply. For Medicare Advantage and Medicaid managed care plans, Anthem is subject to CMS-0057-F, requiring a 72-hour standard and 24-hour expedited decision timeframe.

What are common reasons for Xarelto PA denials from Anthem and how do I appeal?

Common denials include insufficient documentation for medical necessity, failure to complete step therapy, or prescribing a non-formulary drug without exception. Denials are communicated via X12 277/835 or Availity. Appeals follow the standard Anthem operating-company process, with peer-to-peer reviews available.

Does Anthem (Elevance Health) use ePA for Xarelto?

Yes, for retail pharmacy benefit drugs like Xarelto, Anthem (through CarelonRx) accepts electronic prior authorizations via industry-standard ePA partners such as CoverMyMeds and Surescripts, streamlining the submission process for prescribers.